TechMIT Technology Review
Amping up T cells to target cancer
Vaccines that turn the body’s immune system against tumors have shown promise in clinical trials, and a handful have been FDA approved for certain cancers. In many patients, however, these vaccines don’t stimulate enough of a response, and the approach some researchers have taken to strengthening it—delivering the vaccine along with immune-stimulating molecules called cytokines—can…
Join the argument
House rules →Comments load as you scroll.